Using a medication and mobile support to help people with HIV quit smoking in India
Varenicline and mobile behavioral assistance for tobacco cessation in HIV care in India
This study is looking at how well a smoking cessation pill called varenicline works when paired with a helpful mobile phone program for people living with HIV in India, aiming to support current smokers in quitting for good.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-10914986 on NIH RePORTER |
What this research studies
This research investigates the effectiveness of combining varenicline, a medication for quitting smoking, with a mobile phone-based behavioral intervention designed for people living with HIV in India. The study aims to address the high rates of tobacco use among individuals in HIV care by providing tailored support through mobile technology, which is widely accessible in the region. Participants will receive both the medication and behavioral assistance to enhance their chances of quitting smoking successfully. The research will take place at a medical center in Chennai, where many patients are current smokers.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are living with HIV and currently smoke tobacco.
Not a fit: Patients who do not smoke or are not living with HIV may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve smoking cessation rates among people living with HIV, leading to better health outcomes.
How similar studies have performed: Previous studies have shown success with mobile health interventions for smoking cessation in other populations, suggesting a promising approach for this target group.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Kruse, Gina Rae — University of Colorado Denver
- Study coordinator: Kruse, Gina Rae
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.